Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, ...
SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento") today announces it has been awarded a $4.6 million contract from the National Institute of Allergy and ...
SAN DIEGO, April 4, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, ...
SAN DIEGO, March 29, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (SRNEQ) (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat ...
Two months after pandemic lockdowns began, San Diego biotech Sorrento Therapeutics put out a hopeful press release on a COVID-19 breakthrough that some took to tout a cure. 9th Circuit opinion ...
SAN DIEGO, March 17, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (SRNEQ) (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat ...
Sorrento Therapeutics announced the appointment of Mike Royal, MD, as senior vice president of clinical development. Dr. Royal is an anesthesiologist and pain specialist and most recently served as ...
SAN DIEGO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced that the phase 1b study of its non-opioid, afferent nerve ablating drug candidate ...
SAN DIEGO and BOSTON, March 23, 2020 (GLOBE NEWSWIRE) -- In response to the government call for rapidly deployable countermeasures, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento) and SmartPharm ...
The U.S. Justice Department’s bankruptcy watchdog accused Sorrento Therapeutics lawyers of submitting false paperwork to justify the company’s chapter 11 filing in Houston, saying the mailbox location ...
Globavir Biosciences, Inc., a specialty biotechnology company developing small molecule drugs to treat cancer and infectious diseases, and Sorrento Therapeutics, Inc. (NASDAQ: SRNE), an oncology ...
A Texas bankruptcy judge declined to bring monetary sanctions against lawyers for Sorrento Therapeutics, ruling that a bank account and mailbox established to justify the company’s chapter 11 filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback